Filters

Drugs

Showing results (4091-4100 of 7,131) with videos related to

Pageof 714
Sort By:
Drugs|May 1, 1994
Do non-potassium-sparing diuretics increase the risk of sudden cardiac death in hypertensive patients? Recent evidenceA W Hoes, D E Grobbee, T M Peet, et al.
Drugs|May 1, 1994
Treatment of oral Candida mucositis infectionsG E Garber
Drugs|May 1, 1994
Teicoplanin. A reappraisal of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacyR N Brogden, D H Peters
Drugs|June 1, 1994
Tiapride. A review of its pharmacology and therapeutic potential in the management of alcohol dependence syndromeD H Peters, D Faulds
Drugs|June 1, 1994
Histamine H2-receptor antagonists in peptic ulcer disease. Evidence for a prophylactic useJ Nash, L Lambert, M Deakin
Drugs|June 1, 1994
Race and hypertension. What is clinically relevant?D R Rutledge
Drugs|January 1, 1994
Exercise testing in heart failure. A critical reviewK Swedberg
Drugs|January 1, 1994
Vasodilators in heart failure. Conclusions from V-HeFT II and rationale for V-HeFT IIIJ N Cohn
Drugs|January 1, 1994
A new strategy for the treatment of inflammatory pain. Prevention or elimination of central sensitizationC J Woolf
Drugs|January 1, 1994
Current approaches to the treatment and management of chronic lymphocytic leukaemiaE Montserrat, C Rozman
Pageof 714

Showing results (4091-4100 of 7,131) with videos related to

Sort By:
Pageof 714
Drugs|May 1, 1994
Do non-potassium-sparing diuretics increase the risk of sudden cardiac death in hypertensive patients? Recent evidenceA W Hoes, D E Grobbee, T M Peet, et al.
Drugs|May 1, 1994
Treatment of oral Candida mucositis infectionsG E Garber
Drugs|May 1, 1994
Teicoplanin. A reappraisal of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacyR N Brogden, D H Peters
Drugs|June 1, 1994
Tiapride. A review of its pharmacology and therapeutic potential in the management of alcohol dependence syndromeD H Peters, D Faulds
Drugs|June 1, 1994
Histamine H2-receptor antagonists in peptic ulcer disease. Evidence for a prophylactic useJ Nash, L Lambert, M Deakin
Drugs|June 1, 1994
Race and hypertension. What is clinically relevant?D R Rutledge
Drugs|January 1, 1994
Exercise testing in heart failure. A critical reviewK Swedberg
Drugs|January 1, 1994
Vasodilators in heart failure. Conclusions from V-HeFT II and rationale for V-HeFT IIIJ N Cohn
Drugs|January 1, 1994
A new strategy for the treatment of inflammatory pain. Prevention or elimination of central sensitizationC J Woolf
Drugs|January 1, 1994
Current approaches to the treatment and management of chronic lymphocytic leukaemiaE Montserrat, C Rozman
Pageof 714
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us